ACCESS Newswire

Cleverbridge

Share
Cleverbridge Launches CleverInsights to Deliver Accurate, AI-Powered Analytics for Subscription Businesses

The product's easy-to-use dashboards empower companies to accurately benchmark and forecast performance, calculate robust customer health scores, and more.

COLOGNE, GERMANY / ACCESSWIRE / November 30, 2023 / Cleverbridge, a growth engine for global technology companies, today announced the launch of CleverInsights, an advanced analytics suite that leverages AI and 18+ years of eCommerce data to provide unparalleled visibility into recurring revenue, retention, and other essential subscription metrics.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.



Pre-built dashboards for benchmarking, forecasting, anomaly detection, and customer health scoring empower organizations to derive deep insights and optimize performance in near real-time amid an uncertain and ever-changing business environment. These features streamline the reporting process and eliminate the burden of manual and time-consuming analysis, allowing employees to focus on more complex or strategic tasks when most companies are struggling to do more with less.

"As a CEO, I know firsthand how important it is to have accurate reporting. I also know that analysis is resource-intensive, and that too often resulting information is inaccurate, stale, or communicated without the context of broader industry or macroeconomic trends," said Wendi Sturgis, Chief Executive Officer of Cleverbridge. "With CleverInsights, any organization can reliably monitor and optimize recurring revenue with insights that are truly actionable. This grants a distinct competitive advantage, empowers data-driven decision making, and further enables technology companies to grow without adding headcount."

CleverInsights addresses a critical business need with benchmarking and forecasting, two capabilities that help companies interpret and predict key figures tied to recurring revenue with industry-leading levels of accuracy. Organizations can leverage these insights as needed to narrow their strategic focus while other areas of the product run continuously in the background. Anomaly detection, for instance, identifies unexpected changes in key metrics and alerts users to fluctuations along with the probable root causes for spikes or dips, allowing organizations to take immediate action and correct potential issues.

The product's robust customer health scores are calculated with standard inputs along with transaction data such as payment date, payment method, and expansion percentage. These additional data points strengthen the accuracy of health scores and feed into renewal and expansion propensity models that facilitate the effective prioritization of accounts. CleverInsights then recommends the best course of action for each customer, giving organizations the option to trigger automated or semi-automated interventions by leveraging another new Cleverbridge product, CleverAutomations.

General availability of CleverInsights is expected early next year. For more information and to schedule a demo, please visit grow.cleverbridge.com/products/cleverinsights.

About Cleverbridge

Cleverbridge makes it easy to maximize customer lifetime value. We leverage deep eCommerce expertise to orchestrate and automate frictionless self-service transactions across the entire customer journey, empowering customers to purchase, renew, and expand subscriptions in 248 countries and territories globally. For more than 18 years, our Growth Engine has integrated payments with subscription management, lifecycle marketing automation, advanced analytics, and partner ecosystems to consistently deliver recurring revenue growth without added headcount. Learn more at grow.cleverbridge.com.

Contact Information

Gordon Knapp
Senior Director, Marketing
gordon.knapp@cleverbridge.com
+17573458523

SOURCE: Cleverbridge

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/811741/cleverbridge-launches-cleverinsights-to-deliver-accurate-ai-powered-analytics-for-subscription-businesses

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper

Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc

GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release

MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o

GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release

Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring

Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release

DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye